Rie Von-Eyben

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Sorry, we do not have enough data to show an influence graph for this author.
Learn More
PURPOSE To evaluate disease-specific survival (DSS) outcomes in Stage II endometrioid endometrial cancer (EC) patients based on pathology and treatment information including adjuvant radiotherapy and lymph node assessment. METHODS AND MATERIALS Using the Surveillance, Epidemiology, and End Results database, 2877 patients with Stage II EC diagnosed between(More)
  • 1